ライフサイエンスコーパス: dialysate

1 be increased by addition of a sorbent to the dialysate.

2 -methoxytyramine concentrations in rat brain dialysate.

3 ut at the cost of some albumin loss into the dialysate.

4 water (HDO) between blood/body water and the dialysate.

5 s was used to analyze the composition of the dialysate.

6 ction of Ado was also observed in the kidney dialysate.

7 gastric dialysate and 9.17units/mL intestine dialysate.

8 everal unknown peptides that were present in dialysate.

9 sociates with the release of IL-1beta in the dialysate.

10 losed to circulate the therapeutic enzyme in dialysate.

11 0 microM) to increase DA, NE and 5-HT in the dialysate.

12 ord some protection against endotoxin in the dialysate.

13 peritoneal equilibration of fresh peritoneal dialysate.

14 irect measurement of the urea removed in the dialysate.

15 vior and the K(+)-evoked increase in GABA in dialysate.

16 tenuates the K(+)-evoked increase of GABA in dialysate.

17 (changing of temperature) modulation of the dialysate.

18 oxytyramine, and serotonin concentrations in dialysates.

19 Glutamate is significantly elevated in these dialysates.

20 measure smaller amounts of substances in the dialysates.

21 and asparate were readily detectable in EPN dialysates.

22 erved in glutamate levels of arcuate nucleus dialysates.

23 s in glutamate levels within arcuate nucleus dialysates.

24 and TNRNFLRFa were sequenced from hemolymph dialysates.

25 to a significant dose-dependent increase in dialysate (0.3 mg kg(-1): 999+/-287%; 0.5 mg kg(-1): 132

26 ll nicotine exposure paradigms increased VTA dialysate 2-arachidonoyl glycerol (2-AG) levels.

27 d into the MH via a microdialysis probe, and dialysate 5-HT concentrations were measured at 20 min in

28 contained a sample introduction channel for dialysate, a precolumn reactor for derivatization with o

29 detection in protein-free ultrafiltrates or dialysates, a highly sensitive amplification assay was d

30 avenous dipyridamole enhanced resting muscle dialysate adenosine (from 77+/-25 to 147+/-50 nmol/L), a

31 s, respectively, but did not increase muscle dialysate adenosine concentration (from 88+/-21 to 65+/-

32 diabetic rats but SP-LI levels in spinal CSF dialysates after paw formalin injection were significant

33 le-body amino acid turnover studies identify dialysate amino acid loss and reduced protein synthesis

34 ynthesis may be a compensatory adaptation to dialysate amino acid loss with a consequent reduction in

35 heat bread was found as 5.91units/mL gastric dialysate and 9.17units/mL intestine dialysate.

36 ddition, the use of biocompatible peritoneal dialysate and administration of growth hormone independe

37 ulation with calcium-free citrate-containing dialysate and calcium reinjection according to ionic dia

38 oncern has arisen regarding high-bicarbonate dialysate and dialysis-induced alkalemia, but whether th

39 ed, even across species, with plasma-derived dialysate and involves nitric oxide, stromal derived fac

40 epend on the ratio of their concentration in dialysate and plasma (D/P) and the drain volume (Dv) cor

41 Dialysate and plasma cytokines were measured by electroc

42 een peptidoglycan concentrations in recalled dialysate and reports of aseptic peritonitis.

43 The widespread use of bicarbonate dialysate and reprocessed high-efficiency and "high-flux

44 lar weight cutoff dialysis membrane, and the dialysate and retentate were analyzed by UV-visible abso

45 During the test session, dialysate and video recording samples were collected fro

46 ining two substrates were collected into the dialysate and were subsequently analyzed off-line using

47 sfer of bacterial products from contaminated dialysate, and this risk appears to increase with the nu

48 =212) or the 1.75-mmol/L Ca (1.75 Ca; n=213) dialysate arm.

49 iovascular response to HDF or HD with cooled dialysate as assessed with intradialytic MRI.

50 allow enzyme assay reagents to be mixed with dialysate as sample plugs formed.

51 95% CI=0.25 to 0.94, P=0.03), and ultrapure dialysate associated with a lower risk for cardiovascula

52 The times for dialysate at the exit of the bare and hydrogel-coated mi

53 MK-591 reduced LTB4 concentrations in rectal dialysate at the final determination.

54 Successive monitoring of striatal dialysates at a temporal resolution of 7.7 min showed th

55 cess infection, less-than-sterile dialysate, dialysate back leak, and nonbiocompatible membranes in a

56 The dialysate monitor eliminated errors from dialysate bacterial contamination, simplified dialysate

57 a widely varying membrane type, and standard dialysate blood lines.

58 tly increased glutamate release into the CeA dialysate but only after CET.

59 the magnitude of the increase in dopamine in dialysate, but other factors are also involved.

60 ange dopamine concentrations in rat striatal dialysates, but increased those of serotonin by 182% (ac

61 nly used to measure target substances in the dialysates, but other methods such as radioimmunoassay m

62 s were due to peptidoglycan contamination of dialysate by Alicyclobacillus.

63 lculated by dividing the amount recovered in dialysate by the serum area under the curve during hemod

64 antly raised levels of GABA in the recovered dialysates by approximately 40%.

65 udy, we investigated the effects of lowering dialysate Ca level on progression of CAC and histologic

66 Thus, lowering dialysate Ca levels slowed the progression of CAC and im

67 We found a 62% increase in the dialysate [Ca2+] (0.223+/-0.018 to 0.353+/-0.028 mmol/L)

68 Dialysate can be analyzed every 12.5 s using the online

69 ypes, i.e., continuous ambulatory peritoneal dialysate (CAPD), peritoneal, amniotic, pericardial, syn

70 efficiency ratio (net UF volume per gram of dialysate carbohydrate absorbed) were determined at base

71 entration was associated with an increase in dialysate cGMP concentration in both the weal and flare

72 e extracorporeal blood circuit but a minimal dialysate circuit closed to circulate the therapeutic en

73 (28%; P < 0.011), CML-apoB (25%; P < 0.028), dialysate CML (39%; P < 0.03), and dialysate MG output (

74 ; P < 0.011), CML-apoB (67%; P < 0.028), and dialysate CML output (27%; P < 0.01).

75 inserted beneath the soft tissue flap and a dialysate collected every 20 minutes for 4 hours after s

76 D-Serine was detected in dialysate collected from the rat striatum using an onlin

77 The basal dopamine concentration in dialysates collected from the striatum of anesthetized r

78 termination of vasopressin and bradykinin in dialysates collected with 5-min sampling frequency from

79 d to establish thresholds immediately before dialysate collection as well as during each sample colle

80 The results were compared with a total dialysate collection in each patient.

81 bicarbonate dialysate was circulated in the dialysate compartment.

82 During contraction the dialysate concentration increased 154 % above resting co

83 nline, high-speed CE allowing changes in the dialysate concentration of small molecule amine neuroche

84 antitative microdialysis was used to measure dialysate concentration, extracellular concentration and

85 A model was developed to examine serum and dialysate concentrations after intermittent intraperiton

86 toneal cefazolin provides adequate serum and dialysate concentrations for 24 h.

87 The effluent dialysate concentrations of AngI and AngII were measured

88 inserted in the skeletal muscle of rats, and dialysate concentrations of ATP and NE were determined b

89 e n. accumbens of saline-treated rats, basal dialysate concentrations of DA were similar in pups and

90 ure cooled rapidly to near room temperature, dialysate concentrations of glutamate were not increased

91 Dialysate concentrations of glutamate, lactate, and pyru

92 Mean serum and dialysate concentrations were above minimum inhibitory c

93 Dialysate concentrations were below 10 pM for these pept

94 hyroid hormone levels </=300 pg/ml receiving dialysate containing 1.75 or 1.50 mmol/L Ca (n=425) were

95 Dialysates containing high salt concentrations (>150 mM)

96 ut the increased risk of reverse-transfer of dialysate contaminants into the blood compartment.

97 esented a fourfold increase in baseline GABA dialysate content compared with naive rats.

98 Dialysate cooling resulted in a reduction in mean body t

99 D is unclear, VEGF concentrations in drained dialysate correlate with IL-6 levels, suggesting a link

100 al hemodialysis, addition of sorbents to the dialysate could increase the clearance of protein-bound

101 ure and further examine if the use of cooled dialysate could provide protection against hemodialysis-

102 tis count (R = 0.16; 95% CI, 0.03-0.29), and dialysate cytokines.

103 lowing amphetamine are related to changes in dialysate DA concentration as measured with microdialysi

104 dy clearly demonstrate that the magnitude of dialysate DA release is correlated with the magnitude of

105 4 g/dl was dialyzed with a standard clinical dialysate delivery system.

106 vascular access infection, less-than-sterile dialysate, dialysate back leak, and nonbiocompatible mem

107 Mass spectra of in vivo dialysates displayed neuropeptides from 10 peptide famil

108 onists) with cocaine prevents alterations in dialysate dopamine (DA) concentration in the nucleus acc

109 nge drug elicited a much greater increase in dialysate dopamine in isolated vs. nonisolated groups.

110 ous measures of the effects of naltrexone on dialysate dopamine levels in the NAcc and on operant res

111 ecreased the amphetamine-induced increase in dialysate dopamine levels in the striatum.

112 A transient rise in dialysate dopamine levels was observed during the waitin

113 ttenuated the efficacy of ethanol to elevate dialysate dopamine levels.

114 n and prevented ethanol-induced increases in dialysate dopamine levels.

115 Although the use of cooled dialysate during hemodialysis is associated with stabili

116 ndothelial growth factor-C (VEGF-C) in human dialysate effluents, peritoneal tissues, and peritoneal

117 e plasma flow set at 46 +/- 3 ml/min and the dialysate flow (Q(d)) set at 42 +/- 3 ml/min using a hol

118 blood flow was 58.6 (SD 11.7) mL/min, with a dialysate flow of 47.1 (7.8) mL/min.

119 mass transfer area coefficient (KoA) and the dialysate flow rate (Qd).

120 dialyzer; median blood flow rate 400 ml/min; dialysate flow rate 600 ml/min; median hemodialysis time

121 ration profiles for PBUTs and the effects of dialysate flow rate and dialyzer size on PBUT removal.

122 odel simulations suggest that an increase in dialysate flow rate improves the reduction ratio (and re

123 , duration (T: min per treatment), and blood/dialysate flow rates (QB/QD: ml/min) on steady-state con

124 min to 100 mL/min depending on the blood and dialysate flow rates and the type of filter used.

125 rylonitrile filter at combined ultrafiltrate/dialysate flow rates of up to 3 L/hr.

126 The blood and dialysate flow rates, duration of dialysis, type of filt

127 of the level of creatinine in the patient's dialysate fluid in the course of dialysis session.

128 organ tissue area may be in contact with the dialysate fluid.

129 ium balance and factors modulating potassium dialysate fluxes in dialysis, and we review data linking

130 In control rats, SP-LI increased in spinal dialysates following formalin injection and levels were

131 nd was dialyzed against 5 L of acetate-based dialysate for 180 min.

132 ia extracorporeal delivery was active in the dialysate for periods much longer than that in vivo thro

133 zed male rats was used to collect 3.6 microL dialysate fractions that were injected on-line into the

134 Online monitoring of serotonin in striatal dialysate from freely moving rats was carried out for mo

135 c oxide (NO) concentrations were measured in dialysate from healthy human skin, in vivo, both at rest

136 re important for the increase in dopamine in dialysate from NAcc and striatum during sexual behavior

137 Dopamine in dialysate from the nucleus accumbens (NAcc) increases du

138 ls of amino acid neurotransmitters in spinal dialysates from awake, unrestrained control and diabetic

139 Dopamine (DA) levels in dialysates from both areas, as the index of the activity

140 Dialysates from both the VTA and the NAC were collected

141 We found that the peptide concentration in dialysates from the hypothalamus was significantly highe

142 produce low millimolar levels of ethanol in dialysates from the NAcc; water intake was negligible.

143 or S-nitroso-N-acetylpenicillamine decreased dialysate GABA at a 500 microM concentration but increas

144 Formalin injection did not alter dialysate GABA concentrations in control rats, whereas i

145 200 microM L-NAME increased basal dialysate GABA, but to a lesser extent than the 100 micr

146 creatinine (C) and urea (U) and the ratio of dialysate glucose (G) to initial dialysate glucose conce

147 Veratridine caused a steep decrease in dialysate glucose after an initial delay of 7.5 min.

148 he ratio of dialysate glucose (G) to initial dialysate glucose concentration (D/D0) were determined.

149 There was an increase in dialysate glucose in response to the beta-adrenoceptor a

150 or the delay in the delay in the decrease in dialysate glucose.

151 From the difference between infused and dialysate glutamate a value of 3.0 +/- 0.6 microM for th

152 Basal levels of dialysate glutamate were 3.6 +/- 0.5 microM.

153 esults in further and specific elevations in dialysate glutamate.

154 ascular event-free survival between flux and dialysate groups.

155 The fraction of SRFA in the dialysate had a different UV-visible absorption spectrum

156 Dialysate hippocampal purine levels increased during all

157 , P=0.12) and between ultrapure and standard dialysate (HR=0.90, 95% CI=0.61 to 1.32, P=0.60).

158 Dialysate IL-6 concentrations associate with variability

159 Cooled dialysate improved hemodynamic tolerability, and changes

160 ependent increase in GABA release in the CeA dialysate in both CET and naive rats.

161 F80B dialyzers, albumin was detected in the dialysate in four instances (total loss during dialysis,

162 r for creatinine analysis in real samples of dialysate in patients with renal failure.

163 culation does not limit solute exchange with dialysate in the cavity.

164 frame elevates ethanol concentration in NAcc dialysates in a manner consistent with the pattern of et

165 Dialysate insulin and glucose levels were unchanged or e

166 ynamic tolerability achieved by using cooled dialysate is effective at abrogating these effects.

167 ximal effect of addition of a sorbent to the dialysate is equivalent to that of an unlimited increase

168 tudy, it was reported that hemodialysis with dialysate [K+] (KD) of 1.0 or 2.0 mmol/L caused an incre

169 roM glutamate caused a transient increase in dialysate lactate concentration of 72 +/- 17%.

170 Isoprenaline had no effect on dialysate lactate, which was increased by the glutamate

171 a significant increase in nucleus accumbens-dialysate levels of both 5-HT (44% +/- 16, P = 0.002) an

172 By measurement of changes in blood and dialysate levels of calcitriol, there was no evidence of

173 pups, prenatal cocaine exposure led to basal dialysate levels of DA in the n. accumbens that were twi

174 n injection significantly (P<0.05) increased dialysate levels of glutamate, aspartate, taurine, glyci

175 mM probenecid increased dose-dependently the dialysate levels of lactate, but without extracellular a

176 Basal dialysate levels of Met-enkephalin and Leu-enkephalin we

177 xposure to 70% N(2)O significantly increased dialysate levels of oxidation products of NO as well as

178 Striatal dialysate levels were analyzed for dopamine (DA), dihydr

179 ore potential interactions between serum and dialysate magnesium levels and risks associated with dia

180 nd patients with diabetes and that ultrapure dialysate may benefit patients with longer dialysis vint

181 fficult to quantitate during each treatment, dialysate measurements have obvious advantages.

182 ialysate bacterial contamination, simplified dialysate measurements, and proved to be a reliable meth

183 < 0.028), dialysate CML (39%; P < 0.03), and dialysate MG output (40%; P < 0.04).

184 obes were perfused at 0.3 microL/min and the dialysate mixed on-line with 6 mM naphthalene-2,3-dicarb

185 The dialysate monitor eliminated errors from dialysate bacte

186 A multicenter clinical trial of the dialysate monitoring device, the Biostat 1000 (Baxter He

187 tions in amygdalar FAAH activity and reduced dialysate N-arachidonoylethanolamine levels in the CeA.

188 ses in locomotor activity, body temperature, dialysate NE and plasma concentrations of ACTH and corti

189 ases in body temperature and the increase in dialysate NE, and markedly attenuated the increases in p

190 Moreover, the reduction in dialysate NO concentration was associated with a reducti

191 Changes in dialysate NO concentration, measured by electrochemical

192 he hypoglycemia-induced increments in muscle dialysate norepinephrine and epinephrine were similar, s

193 Dialysate norepinephrine concentration was significantly

194 nic volume expansion significantly increased dialysate norepinephrine concentration, while infusion o

195 Dialysate norepinephrine concentrations from these rats

196 centrations from these rats were compared to dialysate norepinephrine content from animals which rece

197 CIA was determined in dialysates obtained from wheat (2.12CI/mL and 3.78CI/mL

198 ncrease in lactate concentration in striatal dialysate of 58 +/- 10%.

199 d CCUG 46822), isolated in Pennsylvania from dialysate of a 77-year-old male with peritonitis.

200 Basal levels of dopamine in the dialysate of the caudate putamen were 4.2+/-0.2 nM in C5

201 dopamine and serotonin release into striatal dialysates of freely moving rats.

202 Prostaglandin E(2) (PGE(2)) was measured in dialysates of lumbar spinal cerebrospinal fluid concurre

203 The concentration of SeMet in the dialysates of the cereals, pulses and GLV ranged from 5.

204 The concentration of SeCys2 in the dialysates of the foods examined was negligible.

205 and cholecystokinin immunoreactive levels in dialysates of the posterior medial nucleus accumbens and

206 icotine SA, but not YA, reduced baseline VTA dialysate oleoylethanolamide (OEA) levels relative to ni

207 effects of high-flux dialysis and ultrapure dialysate on survival of hemodialysis patients are incom

208 s produced no change in VP levels, either in dialysate or plasma.

209 nditions were comprised of 2 L/hr/1.73 m2 of dialysate or prefiltered replacement fluid and hemofilte

210 Dialysate OT levels were 0.3+/-0.1, 2.8+/-1.2 and 1.3+/-

211 but without extracellular acidosis since the dialysate pH was not significantly reduced.

212 est that extreme concentrations of serum and dialysate potassium can trigger cardiac arrest.

213 alysis, and we review data linking serum and dialysate potassium concentrations with arrhythmias, car

214 the overall clinical scenario when choosing dialysate potassium concentrations, and an effective cha

215 e magnesium levels and risks associated with dialysate potassium levels.

216 he effects of both membrane permeability and dialysate purity on cardiovascular outcomes.

217 Peptides in dialysate rapidly degraded when stored at room temperatu

218 ensure that altered substance content in the dialysates reflects changes in release by the brain and

219 /mL and 3.78CI/mL for gastric and intestinal dialysate respectively) and rye breads (4.16CI/mL and 2.

220 /mL and 2.46CI/mL for gastric and intestinal dialysate respectively).

221 A standard addition study on dialysates revealed that while some peptides can be accu

222 or 6 weeks, baseline ACh levels in striatal dialysates rose from 73 fmol/min to 148 or 197 fmol/min

223 xidase to selectively remove D-serine from a dialysate sample.

224 N, extracellular 5-HT was 4 fmol/7.5 micro L dialysate sample.

225 Furthermore, typical dialysate samples (5-15 microL) suffer significant sensi

226 hs were temporally adjusted to correspond to dialysate samples and differentiated according to domina

227 The concentration of glutamate in dialysate samples collected immediately after paw formal

228 In a subsequent study, dialysate samples of norepinephrine were collected befor

229 Dialysate samples of norepinephrine were collected from

230 Dialysate samples were collected and SP-like immunoreact

231 Blood and dialysate samples were collected at the beginning, middl

232 Dialysate samples were collected before and after inject

233 intraperitoneal dosing, serum and peritoneal dialysate samples were obtained at set time intervals ov

234 d; in this group of rats video recording and dialysate samples were obtained when they were placed in

235 ceftazidime concentrations in the serum and dialysate samples.

236 bited a reproducible, oscillating profile of dialysate serotonin concentration versus time.

237 ine, a serotonin uptake inhibitor, increased dialysate serotonin concentrations and stimulated releas

238 Dialysate serotonin concentrations change significantly

239 lly recommended limits for this metal ion in dialysate solution.

240 A continuously flowing dialysate stream from a microdialysis probe was introduc

241 injection of sample from the hydrodynamic MD dialysate stream into a separation channel for analysis

242 ng serial injections, the device allowed the dialysate stream to be analyzed at 130-s intervals.

243 In addition, the elevation in dialysate taurine concentration was greater than that ob

244 Decreasing the dialysate temperature and increasing total dialysis time

245 circuit was -266+/-15 kJ per treatment, and dialysate temperature averaged 35.7+/-0.02 degrees C.

246 ircuit averaged 5+/-31 kJ per treatment, and dialysate temperature averaged 37.1+/-0.02 degrees C.

247 n 6 months were randomized to dialyze with a dialysate temperature of either 37 degrees C or 0.5 degr

248 Dialysate temperature was adjusted to either lower the c

249 a blood temperature monitor with control of dialysate temperature.

250 Dialysate tested negative for galactomannan, demonstrati

251 -plasma ratio of creatinine (D/P Cr) and the dialysate TGF-beta1 concentration.

252 exhibited greater ET-1 addition to the renal dialysate than did control animals (681 +/- 91 versus 29

253 ialysis patients using icodextrin-containing dialysate that met all pharmacopoeia standards, a global

254 ect of addition of activated charcoal to the dialysate then was compared with the effect of increasin

255 aken at timed intervals and in ultrafiltrate/dialysate to determine serum concentration-time profiles

256 Dialysate to plasma (D/P) ratios for creatinine (C) and

257 ients (control, 45; icodextrin, 47) with 4-h dialysate to plasma ratio creatinine >0.70 and D/D(0) gl

258 required the addition of phosphorus into the dialysate to prevent hypophosphatemia.

259 concentration correlated positively with the dialysate-to-plasma ratio of creatinine (D/P Cr) and the

260 uret method, a relatively insensitive assay, dialysate/ultrafiltrate protein losses have been reporte

261 In this study, dialysate/ultrafiltrate protein losses were reanalyzed b

262 stically significant correlation between the dialysate/ultrafiltrate samples and the corresponding va

263 Mean protein concentration for all 22 dialysate/ultrafiltrate samples was 4.2 +/- 4.0 mg/dL.

264 Twenty-two dialysate/ultrafiltrate samples were obtained from Amico

265 n serum protein concentration at the time of dialysate/ultrafiltrate sampling was 4.7 +/- 1.8 g/dL.

266 x dialyzers and either ultrapure or standard dialysate using a two-by-two factorial design.

267 Dialysate VEGF protein collected from the muscle interst

268 Dialysate VEGF-C concentration correlated positively wit

269 and UF targets, respectively; median drained dialysate volume was 16.2 L/24 h with 50% of patients us

270 The lactate concentration in striatal dialysate was assayed using an enzyme-based on-line assa

271 ggest that the decreased IL-6 content in the dialysate was caused principally by tissue alterations o

272 The dialysate was challenged sequentially by 1:1000 and 1:10

273 rough the blood compartment, and bicarbonate dialysate was circulated in the dialysate compartment.

274 Dialysate was collected and analysed for ATP ([ATP](d))

275 Dialysate was collected at baseline and during the ische

276 Dialysate was collected before, during, and following i.

277 Dialysate was collected for the duration of hemodialysis

278 Ethanol in the dialysate was measured by gas chromatography with flame

279 Total albumin loss into the dialysate was measured during each treatment.

280 Approximately 200 micro l of dialysate was recovered every 8-12 h, and the concentrat

281 Aqueous dialysate was segmented into nanoliter plugs by pumping

282 Dialysate was simultaneously collected for later analysi

283 n formalin-evoked SP-LI levels in spinal CSF dialysates was also determined.

284 Median recoveries of drug in dialysate were 9% (INH), 4% (RIF), 45% (PZA), and 2% (EM

285 Lactate and glucose in the dialysate were assayed using enzyme-based on-line assays

286 2.6 nM), although levels in rat spinal cord dialysate were below the limit of detection.

287 d microbiological investigations of recalled dialysate were done.

288 tions highly increased concentrations in the dialysate were observed in tape-stripped skin, whereas t

289 Dialysates were collected and analyzed by high-performan

290 Dialysates were collected every 20 min and dopamine cont

291 Dialysates were derivatized on-line with o-phthaldialdeh

292 dial region of live crabs, and the resulting dialysates were desalted, concentrated, and analyzed by

293 and 3-methoxytyramine in rat brain striatal dialysates were determined before and after the injectio

294 Blank dialysates were negative for enzymatic activity that cou

295 nditions, glutamate concentrations in spinal dialysates were significantly (P<0.05) decreased in diab

296 One hour after contaminating the dialysate with a 1:1000 dilution of the bacterial challe

297 e is integrated with a PDMS chip that merges dialysate with fluorogenic reagent and segments the flow

298 t the study, albumin was undetectable in the dialysate with T220L dialyzers.

299 , during and after TENS and analyzed GABA in dialysates with high performance liquid chromatography.

300 cuit using a calcium-free citrate-containing dialysate, with calcium reinjected according to ionic di